Expansion Momentum With over 70 centers nationwide and recent treatment offerings launched in June 2025, CleanSlate demonstrates ongoing growth and product expansion opportunities. This momentum suggests potential for partnerships, referral networks, and integration of additional services into existing payer and provider ecosystems.

MAT Focus Strength Specialization in medication-assisted treatment for opioid and alcohol use disorders positions CleanSlate as a core partner for health plans, employers, and municipalities seeking scalable addiction care. There is potential to collaborate on value-based contracts around MAT programs, harm reduction initiatives, and long-term recovery support.

Digital & Ops Readiness Adoption of enterprise tools (Salesforce, iCIMS, Microsoft Azure, Smartsheet) indicates mature operations and data capabilities. This enables efficient onboarding of network partners, streamlined referral intake, and robust data sharing with payers and analytics teams for outcome-based proposals.

Clinical Leadership Experienced leadership with ongoing C-suite appointments and clinician-focused leadership signals stability and a patient-centric care model. This creates credibility for pilot programs, clinical research collaborations, and joint grant-funded initiatives targeting higher-need populations.

Outcomes & Scale Strong reported outcomes, including a high 12-week illicit opioid negativity rate, and a sizable patient base (tens of thousands served annually), provide a compelling case for bundled services, performance-oriented pricing, and payer negotiations emphasizing quality metrics and cost savings.